Cargando…
Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease
Risk and manifestations of cardiovascular disease (CVD) in patients infected with human immunodeficiency virus (HIV) will continue to evolve as improved treatments and life expectancy of these patients increases. Although initiation of antiretroviral (ARV) therapy has been shown to reduce this risk,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391206/ https://www.ncbi.nlm.nih.gov/pubmed/25866592 http://dx.doi.org/10.2174/1874613601509010023 |
_version_ | 1782365783233396736 |
---|---|
author | Chastain, Daniel B Henderson, Harold Stover, Kayla R |
author_facet | Chastain, Daniel B Henderson, Harold Stover, Kayla R |
author_sort | Chastain, Daniel B |
collection | PubMed |
description | Risk and manifestations of cardiovascular disease (CVD) in patients infected with human immunodeficiency virus (HIV) will continue to evolve as improved treatments and life expectancy of these patients increases. Although initiation of antiretroviral (ARV) therapy has been shown to reduce this risk, some ARV medications may induce metabolic abnormalities, further compounding the risk of CVD. In this patient population, both pharmacologic and nonpharmacologic strategies should be employed to treat and reduce further risk of CVD. This review summarizes epidemiology data of the risk factors and development of CVD in HIV and provides recommendations to manage CVD in HIV-infected patients. |
format | Online Article Text |
id | pubmed-4391206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Bentham Open |
record_format | MEDLINE/PubMed |
spelling | pubmed-43912062015-04-10 Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease Chastain, Daniel B Henderson, Harold Stover, Kayla R Open AIDS J Article Risk and manifestations of cardiovascular disease (CVD) in patients infected with human immunodeficiency virus (HIV) will continue to evolve as improved treatments and life expectancy of these patients increases. Although initiation of antiretroviral (ARV) therapy has been shown to reduce this risk, some ARV medications may induce metabolic abnormalities, further compounding the risk of CVD. In this patient population, both pharmacologic and nonpharmacologic strategies should be employed to treat and reduce further risk of CVD. This review summarizes epidemiology data of the risk factors and development of CVD in HIV and provides recommendations to manage CVD in HIV-infected patients. Bentham Open 2015-03-31 /pmc/articles/PMC4391206/ /pubmed/25866592 http://dx.doi.org/10.2174/1874613601509010023 Text en © Chastain et al.; Licensee Bentham Open. http://creativecommons.org/licenses/by-nc/3.0/ This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Chastain, Daniel B Henderson, Harold Stover, Kayla R Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease |
title | Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease |
title_full | Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease |
title_fullStr | Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease |
title_full_unstemmed | Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease |
title_short | Epidemiology and Management of Antiretroviral-Associated Cardiovascular Disease |
title_sort | epidemiology and management of antiretroviral-associated cardiovascular disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391206/ https://www.ncbi.nlm.nih.gov/pubmed/25866592 http://dx.doi.org/10.2174/1874613601509010023 |
work_keys_str_mv | AT chastaindanielb epidemiologyandmanagementofantiretroviralassociatedcardiovasculardisease AT hendersonharold epidemiologyandmanagementofantiretroviralassociatedcardiovasculardisease AT stoverkaylar epidemiologyandmanagementofantiretroviralassociatedcardiovasculardisease |